{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:14:46Z","timestamp":1788488086805,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL127342"],"award-info":[{"award-number":["R01HL127342"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL125984"],"award-info":[{"award-number":["K23HL125984"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL111656"],"award-info":[{"award-number":["R01HL111656"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.trsl.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:45:03Z","timestamp":1517561103000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-4194","authenticated-orcid":false,"given":"Santosh L.","family":"Saraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Sysol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Susma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Setty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnamurthy P.","family":"Gudehithlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.L.","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto F.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor R.","family":"Gordeuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2018.01.007_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(12)70055-5","article-title":"Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis","volume":"12","author":"Taylor","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.trsl.2018.01.007_bib0015","doi-asserted-by":"crossref","first-page":"a011783","DOI":"10.1101\/cshperspect.a011783","article-title":"The natural history of sickle cell disease","volume":"3","author":"Serjeant","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.trsl.2018.01.007_bib0020","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjh.12690","article-title":"Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia","volume":"164","author":"Saraf","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0030","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2018.01.007_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","article-title":"Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality","volume":"115","author":"Powars","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2018.01.007_bib0040","doi-asserted-by":"crossref","first-page":"e79923","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2018.01.007_bib0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000183404","article-title":"Renal lesions in sickle cell nephropathy in children","volume":"39","author":"Tejani","year":"1985","journal-title":"Nephron"},{"key":"10.1016\/j.trsl.2018.01.007_bib0050","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.V1111241","article-title":"The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis","volume":"1","author":"Bhathena","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0055","first-page":"357","article-title":"Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome","volume":"77","author":"Elfenbein","year":"1974","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0060","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","article-title":"Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme","volume":"326","author":"Falk","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2018.01.007_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","article-title":"Glomerular lesions in patients with sickle cell disease","volume":"89","author":"Maigne","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.trsl.2018.01.007_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.trsl.2018.01.007_bib0080","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2018.01.007_bib0085","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2016030357","article-title":"African ancestry-specific alleles and kidney disease risk in Hispanics\/Latinos","volume":"28","author":"Kramer","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5830\/CVJA-2014-076","article-title":"Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study","volume":"26","author":"Mukendi","year":"2015","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.trsl.2018.01.007_bib0100","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/ki.1994.403","article-title":"The transgenic SAD mouse: a model of human sickle cell glomerulopathy","volume":"46","author":"De Paepe","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2018.01.007_bib0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2005-07-2839","article-title":"Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease","volume":"107","author":"Manci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2018.01.007_bib0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.trsl.2018.01.007_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ki.1996.301","article-title":"Renal nitric oxide synthases in transgenic sickle cell mice","volume":"50","author":"Bank","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2018.01.007_bib0120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"Paszty","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.trsl.2018.01.007_bib0125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/bcmd.2001.0469","article-title":"Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele","volume":"27","author":"Noguchi","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.trsl.2018.01.007_bib0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/019262302753559597","article-title":"Renal pathology in hemizygous sickle cell mice","volume":"30","author":"Diwan","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0167-4838(88)90117-3","article-title":"Mouse alpha chains inhibit polymerization of hemoglobin induced by human beta S or beta S Antilles chains","volume":"952","author":"Rhoda","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2018.01.007_bib0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1016\/j.trsl.2018.01.007_bib0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.trsl.2018.01.007_bib0150","doi-asserted-by":"crossref","first-page":"e87716","DOI":"10.1371\/journal.pone.0087716","article-title":"MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population","volume":"9","author":"Colares","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trsl.2018.01.007_bib0155","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2018.01.007_bib0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","article-title":"High prevalence of sickle cell trait in African Americans with ESRD","volume":"21","author":"Derebail","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0165","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ki.2011.286","article-title":"Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans","volume":"80","author":"Hicks","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2018.01.007_bib0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bmj.3.5609.34","article-title":"Renal cortical infarcts in sickle-cell trait","volume":"3","author":"Femi-Pearse","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.trsl.2018.01.007_bib0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/cs0590245","article-title":"The influence of indomethacin on renal haemodynamics in sickle cell anaemia","volume":"59","author":"de Jong","year":"1980","journal-title":"Clin Sci"},{"key":"10.1016\/j.trsl.2018.01.007_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22143","article-title":"Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: a case control study","author":"Aloni","year":"2017","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.trsl.2018.01.007_bib0185","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3390\/ijms16034744","article-title":"Transcriptome analysis in rat kidneys: importance of genes involved in programmed hypertension","volume":"16","author":"Tain","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2018.01.007_bib0190","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","article-title":"Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy","volume":"100","author":"Saraf","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2018.01.007_bib0195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/bjh.14724","article-title":"Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon","volume":"178","author":"Geard","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/BJ20121753","article-title":"Physiological and pathological roles of mitochondrial SLC25 carriers","volume":"454","author":"Gutierrez-Aguilar","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2018.01.007_bib0205","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1681\/ASN.2006080894","article-title":"Physiology and pathophysiology of heme: implications for kidney disease","volume":"18","author":"Tracz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature11626","article-title":"Endothelial cell expression of haemoglobin alpha regulates nitric oxide signalling","volume":"491","author":"Straub","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2018.01.007_bib0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.arcmed.2012.05.001","article-title":"Identification of two novel mutations in the SLC4A1 gene in two unrelated Chinese families with distal renal tubular acidosis","volume":"43","author":"Zhang","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1016\/j.trsl.2018.01.007_bib0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12020-010-9340-6","article-title":"A novel SLC4A1 variant in an autosomal dominant distal renal tubular acidosis family with a severe phenotype","volume":"37","author":"Shao","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.trsl.2018.01.007_bib0225","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0609.2011.01739.x","article-title":"dRTA and hemolytic anemia: first detailed description of SLC4A1 A858D mutation in homozygous state","volume":"88","author":"Fawaz","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0230","first-page":"185","article-title":"Aquaglyceroporins in the kidney: present state of knowledge and prospects","volume":"67","author":"Michalek","year":"2016","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0235","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1073\/pnas.96.10.5808","article-title":"Aquaporin-6: an intracellular vesicle water channel protein in renal epithelia","volume":"96","author":"Yasui","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2018.01.007_bib0240","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0002-9343(75)90226-0","article-title":"Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients","volume":"59","author":"Pardo","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2018.01.007_bib0245","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000167444","article-title":"Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study","volume":"7","author":"Bakir","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0250","first-page":"47","article-title":"Membranoproliferative glomerulonephritis associated with sickle cell disease in two siblings","volume":"35","author":"Iskandar","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15513819609169289","article-title":"Microangiopathic glomerulopathy in children with sickle cell anemia","volume":"16","author":"Vogler","year":"1996","journal-title":"Pediatr Pathol Lab Med"},{"key":"10.1016\/j.trsl.2018.01.007_bib0260","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1053\/meta.2002.36302","article-title":"Upregulation of fatty acid synthase gene expression in experimental chronic renal failure","volume":"51","author":"Szolkiewicz","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2018.01.007_bib0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S0007114511002613","article-title":"High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation","volume":"107","author":"Hao","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.trsl.2018.01.007_bib0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ki.2013.354","article-title":"Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis","volume":"85","author":"Barua","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2018.01.007_bib0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1469-1809.2008.00498.x","article-title":"Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans","volume":"73","author":"Leak","year":"2009","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.trsl.2018.01.007_bib0280","doi-asserted-by":"crossref","first-page":"e1002150","DOI":"10.1371\/journal.pgen.1002150","article-title":"Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans","volume":"7","author":"Freedman","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2018.01.007_bib0285","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.trsl.2018.01.007_bib0290","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1681\/ASN.V13165","article-title":"Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes","volume":"13","author":"Arrondel","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0300","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1371\/journal.ppat.0030129","article-title":"Hemoglobin is a co-factor of human trypanosome lytic factor","volume":"3","author":"Widener","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.trsl.2018.01.007_bib0305","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000046610","article-title":"The role of vascular endothelial growth factor in angiogenesis","volume":"106","author":"Ferrara","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0310","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","article-title":"The role of vascular endothelial growth factor (VEGF) in renal pathophysiology","volume":"65","author":"Schrijvers","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2018.01.007_bib0315","first-page":"RA48","article-title":"Ceruloplasmin\u2014acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease","volume":"11","author":"Giurgea","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.trsl.2018.01.007_bib0320","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1320681","article-title":"Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy","volume":"132","author":"Yamazaki","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0325","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1002\/ajh.24965","article-title":"Identification of ceruloplasmin as a biomarker of chronic kidney disease in urine of sickle cell disease patients by proteomic analysis","volume":"93","author":"Jerebtsova","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0330","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajh.22012","article-title":"Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management","volume":"86","author":"Nur","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2018.01.007_bib0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2016.10.020","article-title":"Inflammatory and oxidative stress phenotypes in transgenic sickle cell mice","volume":"62","author":"Charrin","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.trsl.2018.01.007_bib0340","doi-asserted-by":"crossref","first-page":"F739","DOI":"10.1152\/ajprenal.00508.2007","article-title":"Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney","volume":"294","author":"Wang","year":"2008","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418300094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524418300094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T16:20:17Z","timestamp":1636129217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524418300094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":67,"alternative-id":["S1931524418300094"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2018.01.007","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}